Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
Michael SticherlingHautklinik, Universitätsklinikum Erlangen (Clinic of Dermatology, University Hospitals of Erlangen), Erlangen, GermanyAbstract: Cutaneous manifestations of lupus erythematosus (CLE) are manifold, presenting with unspecific skin manifestations or well-defined clinical...
Guardado en:
Autor principal: | Michael Sticherling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94909ae7d09048aa86f43d9437a6b8cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vesiculobullous disease with Cutaneous Systemic Lupus Erythematosus Treated by Rituximab: A case report
por: Wigdan Mohammed Niamat Alla, et al.
Publicado: (2021) -
Old and New Calcineurin Inhibitors in Lupus Nephritis
por: Claudio Ponticelli, et al.
Publicado: (2021) -
An update on belimumab for the treatment of lupus
por: Aikaterini Thanou-Stavraki, et al.
Publicado: (2011) -
B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
por: Wiesik-Szewczyk E, et al.
Publicado: (2012) -
Dermoscopic Appearance of an Annular Subacute Cutaneous Lupus Erythematosus
por: Biswanath Behera, et al.
Publicado: (2021)